Good morning :)
$
₹
Advanced Biomed Inc. Common Stock

Advanced Biomed Inc. Common Stock

ADVB

NASDAQ
Asset Logo

Advanced Biomed Inc. Common Stock

ADVB

NASDAQ
$2.20% (-)
$
₹
$2.20% (-)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Diagnostics & Research

Micro Cap

With a market cap of $3.4M the stock is ranked 6011

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.31
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-5
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

5231.3%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Company Profile

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides developed dye kits used to identify different types of cancer cells. It also offers FinTruth financial verification agent platform, an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. The company was founded in 2014 and is based in Tsuen Wan, Hong Kong.
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides developed dye kits used to identify different types of cancer cells. It also offers FinTruth financial verification agent platform, an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. The company was founded in 2014 and is based in Tsuen Wan, Hong Kong.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Medline Inc. Class A Common Stock
MDLN
M
P/E Ratio
80.07
80.07
1Y Return
16.85%
16.85%
Buy Reco %
85.18
85.18
West Pharmaceutical Services Inc
WST
West Pharmaceutical Services Inc
P/E Ratio
45.77
45.77
1Y Return
45.58%
45.58%
Buy Reco %
93.75
93.75
The Cooper Companies, Inc
COO
The Cooper Companies, Inc
P/E Ratio
21.06
21.06
1Y Return
12.2%
12.2%
Buy Reco %
35.29
35.29
Align Technology Inc
ALGN
Align Technology Inc
P/E Ratio
22.46
22.46
1Y Return
11.26%
11.26%
Buy Reco %
50.00
50.00
Bausch + Lomb Corp
BLCO
Bausch + Lomb Corp
P/E Ratio
—
—
1Y Return
31.21%
31.21%
Buy Reco %
46.66
46.66
Compare with Peers

Forecast

Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

Financials

Financials

Income

Balance Sheet

Cash Flow

6.8
-0.4
0.1
0.6
0.1
0.6
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue0000-0.01000.120.12
Net Income-0.80-0.26-0.90-1.38--0.386.85-0.480.690.69
Net Profit Margin------2249.42%--544.51%544.51%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDiagnostics & Research

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Advanced Biomed Inc. Common Stock -0.31-
Medline Inc. Class A Common Stock80.072.43-
West Pharmaceutical Services Inc45.779.683.21
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare ADVB with any stock or ETF
Compare ADVB with any stock or ETF
Comparing from
ADVB
MDLN
WST
Loading...

Frequently asked questions

  1. Advanced Biomed Inc. Common Stock (ADVB) share price today is $2.20 as of November 5, 2026 at 12:21 AM IST. The stock touched a day high of $2.54 and a day low of $2.15.

  2. Advanced Biomed Inc. Common Stock stock trades on NASDAQ under the ticker symbol ADVB.

  3. Advanced Biomed Inc. Common Stock's market capitalization is $3.42M as of November 5, 2026 at 12:21 AM IST.

  4. Advanced Biomed Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of November 4, 2026.

  5. Advanced Biomed Inc. Common Stock's price-to-book (P/B) ratio is 0.31 as of November 4, 2026.

  6. Yes, You can buy Advanced Biomed Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Advanced Biomed Inc. Common Stock shares in three steps: 1. Search Advanced Biomed Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Advanced Biomed Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Advanced Biomed Inc. Common Stock (ADVB) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 4.5454 shares at the current price of $2.20.

Loading...